At the core of CTOAM's work, Morand explains, is a precision oncology process that integrates multiple diagnostic tools into a single, coordinated pathway. The company supports tumor DNA and RNA sequencing, whole genome liquid biopsies for real-time monitoring, and advanced imaging, including PET-CT scans, depending on what each individual case requires.